Literature DB >> 3490657

Hemodynamic effects of corticotropin releasing hormone in the anesthetized cynomolgus monkey.

R Udelsman, W T Gallucci, J Bacher, D L Loriaux, G P Chrousos.   

Abstract

Right atrial bolus administration of rat/human corticotropin releasing hormone (r/hCRH) at a dose of 90 micrograms/kg to anesthetized cynomolgus monkeys caused a dramatic and prolonged fall in both the peripheral vascular resistance (48% reduction) and mean systemic blood pressure (36% reduction). An associated tachycardia could be blocked with prior propranolol administration and thus was probably reflexic. A mean 43 and 37% increase in the flow of the superior mesenteric and common iliac arteries, respectively, was demonstrated with electromagnetic flow probes. These changes were associated with a concomitant 38 and 40% diminution in the respective vascular resistance. Similar blood flow changes were noted in the carotid artery, however, these were of a much shorter duration. None of these changes occurred in placebo-treated animals. Plasma adrenocorticotropic hormone and cortisol concentrations were elevated basally and throughout the procedure and were similar in the experimental and control groups, suggesting maximal activity of the hypothalamic-pituitary-adrenal axis. Plasma renin activity, however, gradually increased in the r/hCRH-treated animals, probably as a result of the systemic hypotension. We speculate that CRH or a CRH-like substance may function as a paracrine hormone modulating local blood vessel tone and may be important in directing blood flow during stress and injury. The vasoactive properties of exogenous r/hCRH may be of clinical use in man.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3490657     DOI: 10.1016/0196-9781(86)90016-1

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  5 in total

1.  Studies of the role of endothelium-dependent nitric oxide release in the sustained vasodilator effects of corticotrophin releasing factor and sauvagine.

Authors:  D M Barker; R Corder
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

2.  Relaxing actions of corticotropin-releasing factor on rat resistance arteries.

Authors:  S Lei; R Richter; M Bienert; M J Mulvany
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

3.  Intra- and extracerebral blood flow changes and flushing after intravenous injection of human corticotropin-releasing hormone.

Authors:  A Kübler; G Rothacher; V A Knappertz; G Krämer; M Nink; J Beyer; H Lehnert
Journal:  Clin Investig       Date:  1994-05

4.  Regional haemodynamic effects of depressor neuropeptides in conscious, unrestrained, Long Evans and Brattleboro rats.

Authors:  S M Gardiner; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

5.  Corticotropin-Releasing Hormone (CRH) Promotes Macrophage Foam Cell Formation via Reduced Expression of ATP Binding Cassette Transporter-1 (ABCA1).

Authors:  Wonkyoung Cho; Jihee Lee Kang; Young Mi Park
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.